• Explore /
  • Poster
  • / Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: A multicenter, multicohort clinical trial (ALTER-G-001).

Anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumor patients with unresectable liver metastasis: A multicenter, multicohort clinical trial (ALTER-G-001).

Abstract Poster

Authors

null

Jing Liu

Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Jing Liu , Junwei Wu , Liangjun Zhu , Jun Yan , Yong Mao , Xinyu Tang , Lingjun Zhu , Hong Jiang , Xiaowei Wei , Chengfang Shangguan , Wenqi Xi , Yan Shi , Min Shi , Chenfei Zhou , Hui Yang , Jun Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

ChiCTR2100050872

DOI

10.1200/JCO.2022.40.4_suppl.TPS229

Abstract #

TPS229

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ke-Feng Ding

First Author: Junwei Wu

First Author: Yue Liu

First Author: Ke-Feng Ding